Equities analysts expect Perrigo Company plc (NYSE:PRGO) to post sales of $1.09 billion for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Perrigo’s earnings, with estimates ranging from $1.07 billion to $1.12 billion. Perrigo posted sales of $1.29 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 15.5%. The company is scheduled to report its next quarterly earnings report on Monday, March 7th.
On average, analysts expect that Perrigo will report full-year sales of $4.13 billion for the current financial year, with estimates ranging from $4.10 billion to $4.16 billion. For the next financial year, analysts expect that the business will post sales of $4.48 billion, with estimates ranging from $4.36 billion to $4.59 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Perrigo.
Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, November 10th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Perrigo had a positive return on equity of 5.88% and a negative net margin of 5.86%. During the same quarter in the previous year, the company earned $0.93 EPS.
Shares of NYSE PRGO traded down $0.37 during mid-day trading on Friday, hitting $38.83. The stock had a trading volume of 1,068,570 shares, compared to its average volume of 1,520,404. The company has a current ratio of 2.11, a quick ratio of 1.67 and a debt-to-equity ratio of 0.56. Perrigo has a 1 year low of $38.20 and a 1 year high of $50.90. The business’s 50 day moving average price is $44.38. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of -20.65 and a beta of 0.98.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 21st. Shareholders of record on Friday, December 3rd will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date of this dividend is Thursday, December 2nd. Perrigo’s dividend payout ratio (DPR) is -51.06%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PRGO. Amundi Pioneer Asset Management Inc. increased its position in shares of Perrigo by 26.6% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 130,128 shares of the company’s stock valued at $6,267,000 after purchasing an additional 27,379 shares during the last quarter. Ameriprise Financial Inc. grew its stake in shares of Perrigo by 12.2% during the 1st quarter. Ameriprise Financial Inc. now owns 386,166 shares of the company’s stock valued at $15,628,000 after acquiring an additional 42,135 shares during the period. Captrust Financial Advisors grew its stake in shares of Perrigo by 39.6% during the 1st quarter. Captrust Financial Advisors now owns 2,123 shares of the company’s stock valued at $86,000 after acquiring an additional 602 shares during the period. Royal Bank of Canada grew its stake in shares of Perrigo by 88.7% during the 1st quarter. Royal Bank of Canada now owns 41,581 shares of the company’s stock valued at $1,682,000 after acquiring an additional 19,549 shares during the period. Finally, Schonfeld Strategic Advisors LLC grew its stake in shares of Perrigo by 202.9% during the 1st quarter. Schonfeld Strategic Advisors LLC now owns 26,355 shares of the company’s stock valued at $1,066,000 after acquiring an additional 17,655 shares during the period. 88.72% of the stock is owned by hedge funds and other institutional investors.
Perrigo Company Profile
Perrigo Co Plc provides self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Further Reading: What is the S&P 500 Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.